MiRxes Launches Study for Pulmonary Hypertension Biomarkers in Asian Populations
The Singapore-based biotech company will evaluate its miRNA biomarker assay for early detection of pulmonary hypertension as part of the SPHERE study.
The European Commission awarded a consortium of private companies and academic researchers €759,000 recently to carry out their plans.
DiamiR Wins $3.9M in NIH Funding for Neurological Disease Diagnostic Development
The two grants awarded will support DiamiR's development of microRNA diagnostics for mild cognitive impairment, Alzheimer's disease, and Rett syndrome.
MiR Scientific Validates Urine-Based Cancer Tests, Awaits NY State Approval
The firm recently published a study describing three assays for prostate cancer and reporting their sensitivity and specificity in case-control cohort.
The company is seeking NY State approval for its lab, which would allow it to offer both tests as LDTs, hopefully by the end of this year or early next.